Morgan A. Marks

2.9k total citations · 2 hit papers
60 papers, 1.9k citations indexed

About

Morgan A. Marks is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Morgan A. Marks has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 15 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Morgan A. Marks's work include Cervical Cancer and HPV Research (20 papers), Herpesvirus Infections and Treatments (10 papers) and Genital Health and Disease (9 papers). Morgan A. Marks is often cited by papers focused on Cervical Cancer and HPV Research (20 papers), Herpesvirus Infections and Treatments (10 papers) and Genital Health and Disease (9 papers). Morgan A. Marks collaborates with scholars based in United States, Peru and Thailand. Morgan A. Marks's co-authors include Dan Lü, Russell Vang, Ie Ming Shih, Anna Yemelyanova, Malti Kshirsagar, Robert J. Kurman, Patti E. Gravitt, Keith R. Jerome, Michael Boeckh and T. Christopher Mast and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Cancer.

In The Last Decade

Morgan A. Marks

57 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis

2011 386 citations Anna Yemelyanova, Russell Vang et al. Modern Pathology profile →
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

2016 295 citations T. Christopher Mast, Keith R. Jerome et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morgan A. Marks United States	23	1.0k	379	316	271	214	60	1.9k
Henry B Armah United States	24	496 0.5×	411 1.1×	283 0.9×	211 0.8×	419 2.0×	37	1.8k
Xavier Carcopino France	23	826 0.8×	214 0.6×	123 0.4×	570 2.1×	222 1.0×	121	1.8k
Peter Rambau Tanzania	27	351 0.3×	498 1.3×	119 0.4×	474 1.7×	127 0.6×	86	1.6k
José F. Camargo United States	24	790 0.8×	233 0.6×	780 2.5×	148 0.5×	99 0.5×	88	1.8k
Beverly Barton Rogers United States	28	1.1k 1.1×	307 0.8×	660 2.1×	286 1.1×	275 1.3×	109	2.8k
Dorota Nowakowska Poland	22	527 0.5×	131 0.3×	174 0.6×	132 0.5×	117 0.5×	88	1.5k
Carla Carrilho Mozambique	24	524 0.5×	355 0.9×	149 0.5×	309 1.1×	282 1.3×	98	1.7k
Mala Gupta United States	14	492 0.5×	310 0.8×	294 0.9×	132 0.5×	263 1.2×	32	1.4k
C Quéreux France	20	1.1k 1.0×	190 0.5×	87 0.3×	482 1.8×	242 1.1×	89	1.7k
Clare A. Dykewicz United States	15	821 0.8×	248 0.7×	450 1.4×	142 0.5×	114 0.5×	22	1.6k

Countries citing papers authored by Morgan A. Marks

Since Specialization

Citations

This map shows the geographic impact of Morgan A. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan A. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan A. Marks more than expected).

Fields of papers citing papers by Morgan A. Marks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan A. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan A. Marks. The network helps show where Morgan A. Marks may publish in the future.

Co-authorship network of co-authors of Morgan A. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan A. Marks. A scholar is included among the top collaborators of Morgan A. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan A. Marks. Morgan A. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Araujo, Andre B., Alina Bogdanov, Ni Zeng, et al.. (2024). Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United States. Open Forum Infectious Diseases. 11(12). ofae695–ofae695. 8 indexed citations

Beck, Ekkehard, Elisha Beebe, Daina B. Esposito, et al.. (2024). Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States. Infectious Diseases and Therapy. 14(1). 199–216. 5 indexed citations

Bush, Christopher, Katherine E. Mues, Ekkehard Beck, et al.. (2024). Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States. Vaccine. 42(25). 126113–126113. 4 indexed citations

Bausch-Jurken, Mary T., Rachel Dawson, Francesca Ceddia, et al.. (2024). A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines. Expert Review of Vaccines. 23(1). 914–943.

Panter, Charlotte, Kevin L. Russell, Madelyn Ruggieri, et al.. (2023). Measuring dengue illness intensity: Development and content validity of the dengue virus daily diary (DENV-DD). Journal of Patient-Reported Outcomes. 7(1). 84–84.

Klein, Nicola P., Joan Bartlett, Bruce Fireman, et al.. (2023). Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. BMJ. 383. e076321–e076321. 18 indexed citations

Amend, Kandace L., Li Zhou, Morgan A. Marks, et al.. (2021). Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012–2016. Vaccine. 40(4). 682–688. 1 indexed citations

Duke, Elizabeth R., Brian D. Williamson, Bhavesh Borate, et al.. (2020). CMV viral load kinetics as surrogate endpoints after allogeneic transplantation. Journal of Clinical Investigation. 131(1). 40 indexed citations

Marks, Morgan A., Adam Gater, Amy C. Morrison, et al.. (2019). PIN96 DEVELOPMENT OF PATIENT-REPORTED OUTCOME (PRO) AND OBSERVER-REPORTED OUTCOME (OBSRO) MEASURES FOR ASSESSMENT OF SYMPTOM INTENSITY IN DENGUE ILLNESS. Value in Health. 22. S210–S210. 1 indexed citations

10.

Klein, Nicola P., Joan Bartlett, Bruce Fireman, et al.. (2019). Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention. Vaccine. 37(36). 5422–5427. 26 indexed citations

11.

Okamoto, Emi, Morgan A. Marks, Enzo Fortuny, et al.. (2015). Biomarkers and Mortality in Severe Chagas Cardiomyopathy. Global Heart. 10(3). 173–173. 29 indexed citations

12.

Gilman, Robert H., et al.. (2015). Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, Peru. Sexually Transmitted Infections. 92(2). 149–154. 21 indexed citations

13.

Poli, Usha Rani, et al.. (2015). Correlation of plasma nitrite/nitrate levels and inducible nitric oxide gene expression among women with cervical abnormalities and cancer. Nitric Oxide. 52. 21–28. 15 indexed citations

14.

Martin, Diana L., Morgan A. Marks, Lisbeth Ferrufino, et al.. (2014). Regional Variation in the Correlation of Antibody and T-Cell Responses to Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene. 90(6). 1074–1081. 20 indexed citations

15.

Okamoto, Emi, Eva H. Clark, Morgan A. Marks, et al.. (2014). Biomarkers in Trypanosoma cruzi-Infected and Uninfected Individuals with Varying Severity of Cardiomyopathy in Santa Cruz, Bolivia. PLoS neglected tropical diseases. 8(10). e3227–e3227. 28 indexed citations

16.

Fakhry, Carole, Morgan A. Marks, Robert H. Gilman, et al.. (2013). Comparison of the immune microenvironment of the oral cavity and cervix in healthy women. Cytokine. 64(2). 597–604. 20 indexed citations

17.

Marks, Morgan A., Charles S. Rabkin, Eric A. Engels, et al.. (2012). Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS. 27(3). 469–474. 50 indexed citations

18.

Halsey, Eric S., Morgan A. Marks, Eduardo Gotuzzo, et al.. (2012). Correlation of Serotype-Specific Dengue Virus Infection with Clinical Manifestations. PLoS neglected tropical diseases. 6(5). e1638–e1638. 73 indexed citations

19.

Yemelyanova, Anna, Russell Vang, Malti Kshirsagar, et al.. (2011). Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Modern Pathology. 24(9). 1248–1253. 386 indexed citations breakdown →

20.

Klein, Sabra L., Morgan A. Marks, Wei Li, et al.. (2011). Sex Differences in the Incidence and Case Fatality Rates From Hemorrhagic Fever With Renal Syndrome in China, 2004–2008. Clinical Infectious Diseases. 52(12). 1414–1421. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact